Author
The U.S. Department of Justice (DOJ), representing the president’s administration, has taken aim at three of the nation’s top medical schools.
Health care is consistently ranked among the top concerns of the nation’s voters. A special issue for health care voters is electing candidates who are committed to making high-quality health care accessible and affordable to all.
Affirmative action in higher education may soon be abolished by the Supreme Court. The consequences for the physician workforce may be dire.
A review of key decisions from the Supreme Court’s 2021-2022 term, including rulings on abortion, concealed carry, and regulatory authority.
It is more crucial than ever that women have unfettered access to contraception at no charge.
An ongoing patent battle over omega-3 fatty acids may have broad implications for the marketing of generic drugs.
For the generic drug and biosimilar industries, the Supreme Court’s recent decision in United States v. Arthrex, Inc. comes as a relief.
How the Court decides United States v. Arthrex will have important implications for patent law and for administrative law more generally.
Three developments may have effects on the use of patents to fend off competition for therapeutic monoclonal antibodies.
The purpose of the secondary patent filings was to assemble a thicket of patents, 132 in all, to prohibit competition from biosimilar companies.
